Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference

News provided by

May 23, 2013, 05:21 ET

THOUSAND OAKS, Calif., May 23, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Deutsche Bank 38^th Annual Healthcare Conference on Thursday, May 30, 2013, at the Westin Boston Waterfront Hotel, Boston, beginning at 9:20 a.m. Eastern Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Eric Hyllengren, 805-447-79898 (investors)

SOURCE Amgen